κ-Opioid receptors and analgesia

https://doi.org/10.1016/0165-6147(90)90321-XGet rights and content

Abstract

Over the past decade, opioids have attracted great attention. One important reason for this is the need for novel, strong analgesics free of the abuse potential and side-effects of narcotics such as morphine. Because morphine acts at μ-opioid receptors, efforts have been made to characterize analgesia mediated by non-μ sites, in particular κ-opioid receptors. There is now good evidence that κ-receptors do indeed mediate analgesia. However, κ-agonists display properties that could curtail their therapeutic exploitation. Since the first selective κ-agonists are now entering clinical trials, this is an opportune moment for Mark Millan to review the pharmacology of drugs of this type in the control of nociception and their therapeutic potential as analgesics.

References (39)

  • M.J. Millan

    Pain

    (1986)
  • H. Khachaturian et al.

    Trends Neurosci.

    (1985)
  • M.J. Millan et al.

    Brain Res.

    (1987)
  • M.J. Millan et al.

    Neurosci. Lett.

    (1981)
  • A.E. Panerai et al.

    Brain Res.

    (1984)
  • M.J. Millan

    Pain

    (1988)
  • V. Höllt et al.

    Neurosci. Lett.

    (1987)
  • H.W. Sander et al.

    Brain Res.

    (1988)
  • H.W. Sander et al.

    Eur. J. Pharmacol.

    (1989)
  • J. Calthrop et al.

    Life Sci.

    (1983)
  • S.M. Fleetwood-Walker et al.

    Brain Res.

    (1988)
  • D.J. Calcagnetti et al.

    Eur. J. Pharmacol.

    (1988)
  • T.L. Yaksh

    Brain Res.

    (1988)
  • M. Pohl

    Neurosci. Lett.

    (1989)
  • T.S. Shippenberg et al.

    Pain

    (1988)
  • J. Traynor

    Trends Pharmacol. Sci.

    (1989)
  • J.M. Jaffe et al.
  • G.W. Pasternak

    J. Am. Med. Assoc.

    (1988)
  • D.C. Horwell

    Drugs Future

    (1988)
  • Cited by (0)

    View full text